MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1623.57%
Quick Ratio
1623.57%
Cash Ratio
249.02%
Debt to Asset Ratio
6.59%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, available...
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Current liabilities held for sal...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
72,319
33,211
61,148
46,003
Marketable securities, available for sale
388,390
466,351
468,961
517,337
Prepaid expenses and other assets
6,445
10,230
13,276
10,560
Current assets held for sale
4,364
-
-
-
Total current assets
471,518
509,792
543,385
573,900
Property and equipment, net
6,892
7,396
7,831
8,129
Operating lease right-of-use asset
1,278
1,334
1,387
1,437
Total assets
479,688
518,522
552,603
583,466
Accounts payable
4,666
7,293
6,006
6,157
Accrued compensation
8,576
5,678
12,430
7,998
Accrued other expenses
5,189
8,555
7,920
6,483
Operating lease liability, current portion
1,021
1,017
1,014
1,008
Current liabilities held for sale
9,590
-
-
-
Total current liabilities
29,042
22,543
27,370
21,646
Operating lease liability, net of current portion
2,569
2,776
2,976
3,173
Total liabilities
31,611
25,319
30,346
24,819
Common stock, .0001 par value per share 1,000,000,000 shares authorized as of june 30, 2026 and december 31, 2025 107,776,380 shares and 106,249,579 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
10
10
10
10
Additional paid-in capital
1,101,278
1,088,829
1,067,941
1,054,091
Accumulated other comprehensive income (loss)
-500
-252
677
701
Accumulated deficit
-652,711
-595,384
-546,371
-496,155
Total stockholders' equity
448,077
493,203
522,257
558,647
Total liabilities and stockholders' equity
479,688
518,522
552,603
583,466
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities,available for sale$388,390K (-29.46%↓ Y/Y)Cash and cashequivalents$72,319K (66.62%↑ Y/Y)Prepaid expenses andother assets$6,445K (-30.42%↓ Y/Y)Current assets held forsale$4,364K Total current assets$471,518K (-21.84%↓ Y/Y)Property and equipment,net$6,892K (-19.81%↓ Y/Y)Operating leaseright-of-use asset$1,278K (-13.88%↓ Y/Y)Total assets$479,688K (-21.79%↓ Y/Y)Total liabilities andstockholders' equity$479,688K (-21.79%↓ Y/Y)Total stockholders'equity$448,077K (-23.93%↓ Y/Y)Total liabilities$31,611K (30.28%↑ Y/Y)Accumulated deficit-$652,711K (-43.30%↓ Y/Y)Accumulated othercomprehensive income (loss)-$500K (-345.10%↓ Y/Y)Additional paid-in capital$1,101,278K (5.45%↑ Y/Y)Total currentliabilities$29,042K (38.98%↑ Y/Y)Operating leaseliability, net of current...$2,569K (-23.70%↓ Y/Y)Common stock, .0001 parvalue per share...$10K (0.00%↑ Y/Y)Current liabilitiesheld for sale$9,590K Accrued compensation$8,576K (52.16%↑ Y/Y)Accrued other expenses$5,189K (-12.58%↓ Y/Y)Accounts payable$4,666K (-43.92%↓ Y/Y)Operating leaseliability, current portion$1,021K (1.69%↑ Y/Y)

Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics, Inc. (EWTX)